促进苯二氮䓬类及其他镇静催眠药去处方的干预措施效果比较:系统综述与Meta分析
该系统综述与Meta分析纳入49项随机对照试验、逾39000例使用苯二氮䓬类及相关镇静催眠药(BSH)治疗失眠的成人,评估多种去处方策略。低确定性证据提示患者教育、药物审查和药师主导的教育干预可能提高BSH停药比例;中等确定性证据提示患者教育对躯体功能、心理健康和失眠症状可能几乎无影响。
要点
- 患者教育、药物审查和药师主导教育干预可能提高BSH停药比例(低确定性证据)。
- 患者教育对躯体功能、心理健康和失眠症状可能几乎无影响(中等确定性证据)。
- 多组分干预可能比单组分干预更有效促进BSH停药(低确定性证据)。
核心结论
- 关于停用BSH干预措施有效性的证据确定性低。
- 患者教育、药物审查和药师主导的教育干预可能提高停用BSH的患者比例。
研究设计与样本
- 系统综述与随机对照试验Meta分析,检索MEDLINE、Embase、CINAHL、PsycInfo和CENTRAL自建库至2024年8月,并检索纳入研究和类似系统综述的参考文献列表。
- 纳入49项独特试验、逾39000例使用BSH治疗失眠的成人,干预分为减量、患者教育、医生教育、患者与医生联合教育、认知行为疗法、药物审查、正念、动机性访谈、药师主导干预及药物辅助减量与戒断等类别。
主要发现
- 低确定性证据提示,与常规照护相比,患者教育每1000例患者多144例(95%CI 61至246)停药,药物审查每1000例多104例(95%CI 34至191)停药,药师主导的教育干预每1000例多491例(95%CI 234至928)停药。
- 中等确定性证据提示,患者教育对躯体功能、心理健康和失眠症状可能几乎无影响。
- 药物审查或药师主导教育干预对其他结局无证据。
- 无令人信服的证据表明其他干预可能帮助患者停用BSH。
- 无高或中等确定性证据表明任何干预导致脱落增加。
局限性
- 关于停用BSH干预措施有效性的证据确定性低。
- 药物审查或药师主导教育干预对其他结局无证据。
- 无令人信服的证据表明其他干预可能帮助患者停用BSH。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To review evidence from randomised trials assessing the effectiveness of strategies to deprescribe benzodiazepines and closely related sedative hypnotics (BSH). DESIGN: Systematic review and meta-analysis of randomised controlled trials. DATA SOURCES: MEDLINE, Embase, CINAHL, PsycInfo, and CENTRAL, searched from inception to August 2024, and reference lists of included studies and similar systematic reviews. ELIGIBILITY CRITERIA FOR SELECTING STUDIES: Eligible studies randomised adults using BSH for insomnia to interventions aimed at deprescribing BSH, strategies to implement these interventions in healthcare settings, or usual care or placebo. METHODS: Reviewers worked independently and in duplicate to screen search results, extract data, and assess risk of bias. Similar interventions were grouped together, frequentist random effects meta-analysis was conducted, and the certainty of evidence was assessed using the GRADE (Grading of Recommendations Assessment, Development, and Evaluation) approach. RESULTS: The review identified 58 publications reporting on 49 unique trials with more than 39 000 patients. Interventions were classified into the following categories: tapering, patient education, physician education, combined patient and physician education, cognitive behavioural therapy, medication review, mindfulness, motivational interviewing, pharmacist led interventions, and drug assisted tapering and withdrawal. Low certainty evidence suggests that education of patients (144 (95% confidence interval 61 to 246) more per 1000 patients), medication review (104 (34 to 191) more), and a pharmacist led educational intervention (491 (234 to 928) more) may increase the proportion of patients who discontinue BSH compared with usual care. Moderate certainty evidence suggests that education of patients probably has little or no effect on physical function, mental health, and signs and symptoms of insomnia. No evidence was found regarding these other outcomes for medication review or for the pharmacist led educational intervention. No compelling evidence was found that other interventions may help patients to discontinue BSH. Moreover, no high or moderate certainty evidence was found that any of the interventions caused an increase in dropouts. Finally, low certainty evidence suggests that multicomponent interventions may be more effective at facilitating discontinuation of BSH than single component interventions. CONCLUSION: The evidence on the effectiveness of interventions to discontinue BSH is of low certainty. Educating patients, doing medication reviews, and a pharmacist led educational intervention may increase the proportion of patients who discontinue BSH.
引用
- Zeraatkar D, Nagraj SK, Ling M, et al. Comparative effectiveness of interventions to facilitate deprescription of benzodiazepines and other sedative hypnotics: systematic review and meta-analysis. BMJ. 2025. PMID: 40527546. doi:10.1136/bmj-2024-081336
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。